Pharmacological interventions for cognitive decline in people with Down syndrome-Reference-Cited by-同舟云学术

Pharmacological interventions for cognitive decline in people with Down syndrome

Published:2015-10-29 Issue:10 Volume:2015 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Livingstone Nuala¹,Hanratty Jennifer¹,McShane Rupert²,Macdonald Geraldine³

Affiliation:

1. Queen's University Belfast; School of Sociology, Social Policy and Social Work; 6 College Park Belfast UK BT7 1LP

2. University of Oxford; Radcliffe Department of Medicine; John Radcliffe Hospital Level 4, Main Hospital, Room 4401C Oxford Oxfordshire UK OX3 9DU

3. University of Bristol; School for Policy Studies; Priory Road Bristol UK BS8 1TZ

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD011546.pub2/fullpdf

Reference106 articles.

1. Antagonism of NMDA receptors as a potential treatment for Down syndrome: a pilot randomized controlled trial;Boada;Translational Psychiatry,2012

2. On the promise of pharmacotherapies targeted at cognitive and neurodegenerative components of Down syndrome;Costa;Developmental Neuroscience,2011

3. Costa ACS Query re Memantine and Down syndrome [personal communication] Email to: N Livingstone

4. NCT01112683 Efficacy and safety of memantine hydrochloride in enhancing the cognitive abilities of young adults with Down syndrome clinicaltrials.gov/ct2/show/NCT01112683

5. Cooper SA TOP-COG study [personal communication] Email to: R McShane

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cognitive Impairment in the Primary Care Clinic;Primary Care: Clinics in Office Practice;2024-06

2. Unlocking cognitive potential: a comprehensive review of neurocognitive interventions in Down Syndrome;InterConf;2024-03-20

3. Turning the Spotlight to Cholinergic Pharmacotherapy of the Human Language System;CNS Drugs;2023-06-21

4. Enfermedad de Alzheimer y síndrome de Down;Medicina de Familia. SEMERGEN;2023-05

5. Diseases Affecting Middle-Aged and Elderly Individuals With Trisomy 21;DTSCH ARZTEBL INT;2023